Lissinda H du Plessis (Lissinda H Du Plessis)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 12

Top Venues

PloS one

Biomedical materials (Bristol, England)

Microorganisms

Pharmaceuticals (Basel, Switzerland)

North-West University

North West University Faculty of Health Sciences (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

North-West University Jan 01 2013

South Africa

Associate Professor :: Clinical Pharmacy

Education History

North West University Faculty of Health Sciences

South Africa

PHD

Publications

Daria A Rutkowska, Lissinda H du Plessis, Essa Suleman, Martha M O'Kennedy, Deepak B Thimiri Govinda Raj, Yolandy Lemmer
Development of a Plant-Expressed Subunit Vaccine against Brucellosis. Microorganisms 12 (6) (2024)
Martha M O'Kennedy, Robyn Roth, Karen Ebersohn, Lissinda H du Plessis, Sipho Mamputha, Daria A Rutkowska, Ilse du Preez, Jan A Verschoor, Yolandy Lemmer
Immunogenic profile of a plant-produced nonavalent African horse sickness viral protein 2 (VP2) vaccine in IFNAR-/- mice. PloS one 19 (4) (2024)
Maryke de Villiers, Awie F Kotzé, Lissinda H du Plessis
Pneumatic extrusion bioprinting-based high throughput fabrication of a melanoma 3D cell culture model for anti-cancer drug screening. Biomedical materials (Bristol, England) 19 (5) (2024)
Martha M O'Kennedy, Robyn Roth, Karen Ebersohn, Lissinda H du Plessis, Sipho Mamputha, Daria A Rutkowska, Ilse du Preez, Jan A Verschoor, Yolandy Lemmer
Immunogenic profile of a plant-produced nonavalent African horse sickness viral protein 2 (VP2) vaccine in IFNAR-/- mice. PloS one 19 (4) (2024)
Daria A Rutkowska, Lissinda H du Plessis, Essa Suleman, Martha M O'Kennedy, Deepak B Thimiri Govinda Raj, Yolandy Lemmer
Development of a Plant-Expressed Subunit Vaccine against Brucellosis. Microorganisms 12 (6) (2024)
Martha M O'Kennedy, Robyn Roth, Karen Ebersohn, Lissinda H du Plessis, Sipho Mamputha, Daria A Rutkowska, Ilse du Preez, Jan A Verschoor, Yolandy Lemmer
Immunogenic profile of a plant-produced nonavalent African horse sickness viral protein 2 (VP2) vaccine in IFNAR-/- mice. PloS one 19 (4) (2024)
Maryke de Villiers, Awie F Kotzé, Lissinda H du Plessis
Pneumatic extrusion bioprinting-based high throughput fabrication of a melanoma 3D cell culture model for anti-cancer drug screening. Biomedical materials (Bristol, England) (2024)
Maryke de Villiers, Lissinda H du Plessis
Flow Cytometry as an analytical method of drug-induced apoptosis in 3D bioprinted melanoma cells. Biomedical materials (Bristol, England) (2023)
Eun Bin Seo, Lissinda H du Plessis, Joe M Viljoen
Solidification of Self-Emulsifying Drug Delivery Systems as a Novel Approach to the Management of Uncomplicated Malaria. Pharmaceuticals (Basel, Switzerland) 15 (2) (2022)
Christi A Wilkins, Lissinda H du Plessis, Joe M Viljoen
Investigating In Vitro and Ex Vivo Properties of Artemether/Lumefantrine Double-Fixed Dose Combination Lipid Matrix Tablets Prepared by Hot Fusion. Pharmaceutics 13 (7) (2021)
Mduduzi N Sithole, Suzanne Marais, Sumari M Maree, Lissinda H du Plessis, Jeanetta Du Plessis, Minja Gerber
Development and characterization of nano-emulsions and nano-emulgels for transdermal delivery of statins. Expert opinion on drug delivery 18 (6) (2021)
Christi A Wilkins, Lissinda H du Plessis, Joe M Viljoen
Characterization of solid lipid dispersions prepared by hot fusion containing a double-fixed dose combination of artemether and lumefantrine. Drug development and industrial pharmacy 46 (8) (2020)

Lissinda H du Plessis.css-eqlu8i{font-size:small;padding-left:4px;} (Lissinda H Du Plessis)

Publication Activity (10 Years)

Top Topics

Top Venues

Lissinda H du Plessis (Lissinda H Du Plessis)